Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Andrew Thomas takes up UK comms agency role

Joins London-based Red Door Communications as head of international

Red Door Communications Pfizer Andrew ThomasPfizer's Andrew Thomas has moved agency-side to take up the role of head of international at London-based healthcare agency Red Door Communications.

Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada.

During this time, he handled a portfolio that included many of the company's highest profile medicines and led campaigns that were later recognised and celebrated at PMEA and Communiqué Awards.

“My time at Pfizer,” Thomas said, “required me to work across complex organisational structures and to understand what works, what doesn't and, most importantly, why that was the case.

“Success in that role was ultimately predicated on an ability to build, maintain and cultivate effective relationships based on trust and shared ownership with internal and external stakeholders alike.

“I believe those skills mean I will be able to make a real contribution to the Red Door Communications team and help develop their existing international offering still further”.

Thomas spent six years at Pfizer and prior to serving at the pharma company he worked at comms agencies Lowe Fusion and then Cohn and Wolfe.

Commenting on the appointment, Catherine Warne, head of Creston Health Group, said: “I have known Andrew for many years as a competitor and then a client. He is great fun, hugely well liked and respected in our industry and a proven influencer at a senior level.

“We are very excited that he is joining us and believe he is the ideal person to drive our international business."

7th September 2012

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...